These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25696573)

  • 1. Angiotensin II receptor antagonists (AT
    van Zwieten PA
    Neth Heart J; 2006 Nov; 14(11):381-387. PubMed ID: 25696573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of angiotensin II receptor antagonists.
    Timmermans PB
    Can J Cardiol; 1999 Nov; 15 Suppl F():26F-8F. PubMed ID: 10579749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The place of ARBs in heart failure therapy: is aldosterone suppression the key?
    Markan U; Pasupuleti S; Pollard CM; Perez A; Aukszi B; Lymperopoulos A
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719868134. PubMed ID: 31401939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of AT1-receptor blockers.
    Unger T
    Blood Press Suppl; 2001; (3):5-10. PubMed ID: 11683476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
    Kakuta H; Sudoh K; Sasamata M; Yamagishi S
    Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta.
    Nap A; Balt JC; Pfaffendorf M; Van Zwieten PA
    J Hypertens; 2002 Sep; 20(9):1821-8. PubMed ID: 12195125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AT1 receptor antagonist therapy in patients with severe heart failure pretreated with angiotensin-converting enzyme inhibitors.
    Gremmler B; Kunert M; Kisters K; Schleiting H; Ulbricht LJ
    Exp Clin Cardiol; 2002; 7(4):193-8. PubMed ID: 19644591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor antagonist treatment during pregnancy.
    Alwan S; Polifka JE; Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2005 Feb; 73(2):123-30. PubMed ID: 15669052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics.
    Timmermans PB
    Hypertens Res; 1999 Jul; 22(2):147-53. PubMed ID: 10487332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blockers: review of the binding characteristics.
    Siragy H
    Am J Cardiol; 1999 Nov; 84(10A):3S-8S. PubMed ID: 10588088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.
    Michel MC; Foster C; Brunner HR; Liu L
    Pharmacol Rev; 2013 Apr; 65(2):809-48. PubMed ID: 23487168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of angiotensin (AT1) receptor antagonists: potential contribution of mechanisms other than AT1 receptor blockade.
    Schmidt B; Drexler H; Schieffer B
    Am J Cardiovasc Drugs; 2004; 4(6):361-8. PubMed ID: 15554721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.